Literature DB >> 26016312

[Definitive contraception with Essure device: Single institutional experience on 517 procedures].

Pablo Aparicio-Rodríguez-Miñón, Jesús de la Fuente-Valero, Ana Martínez-Laral, Ana Alonso-García, Verónica Sobrino-Mota, Ignacio Zapardiel-Gutiérrez, Juan J Hernández-Aguado.   

Abstract

OBJECTIVES: To analyse the outcomes of patients undergoing Essure sterilization in a single institution, interns of complications and technique failure. PATIENTS AND METHODS: Retrospective descriptive study of 517 patients underwent definitive contraception with Essure device in outpatient hysteroscopy office without anesthesia and controlled at 3 months with abdominal radiography, ultrasonography and hysterosalpingography in selected cases.
RESULTS: The success rates of the insertion of Essure was 96.8%, similar to data reported in the literature with 3.7% of vagal reactions, as most prevalent complication. 7 (1.35%) unintended pregnancies were observed.
CONCLUSIONS: Essure is a permanent birth control device, with high rate of successful insertion and a low rate of complications. Unintended pregnancies in our study are high and we must change the protocols of placement and monitoring, considering hysterosalpingography as a routine control test.

Entities:  

Mesh:

Year:  2015        PMID: 26016312

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  1 in total

1.  Initial experience with hysteroscopic tubal occlusion (Essure®).

Authors:  Daniella De Batista Depes; Ana Maria Gomes Pereira; Umberto Gazi Lippi; João Alfredo Martins; Reginaldo Guedes Coelho Lopes
Journal:  Einstein (Sao Paulo)       Date:  2016 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.